Once the malicious software was detected, Bio-Rad immediately took certain systems offline, the company said in a filing with the Securities & Exchange Commission. Shares in BIO reached a low of $343.73 when the news broke on Tuesday, but have since recovered to $354.62. That’s still down 5% from its opening price on Monday, Dec. 9.
Work is ongoing to restore the full system as quickly as possible, according to the Hercules, Calif.–based life science research and clinical diagnostics manufacturer. Customers may experience delays in placing orders while the company’s systems are down, but Bio-Rad said it has found no evidence of unauthorized access, transfer, or misuse of data or personal information.
“We appreciate the patience and understanding of our customers as we work to re-establish our systems following this attack,” said Bio-Rad president & CEO Norman Schwartz in a news release. “I would like to recognize the incredible work of Bio-Rad employees around the world this past week and commend their outstanding efforts to minimize disruption to our customers as we navigated this situation.”